Andrew Creamer

3.0k total citations · 1 hit paper
23 papers, 374 citations indexed

About

Andrew Creamer is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, Andrew Creamer has authored 23 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 4 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Physiology. Recurrent topics in Andrew Creamer's work include Lung Cancer Diagnosis and Treatment (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Andrew Creamer is often cited by papers focused on Lung Cancer Diagnosis and Treatment (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Andrew Creamer collaborates with scholars based in United Kingdom, United States and Greece. Andrew Creamer's co-authors include Shaney Barratt, Nazia Chaudhuri, Conal Hayton, Mahableshwar Albur, Barbara Hazard Munro, J. M. Keep, Jennifer Dickson, Anna Duckworth, Felix Woodhead and Chris J. Scotton and has published in prestigious journals such as CHEST Journal, Thorax and Critical Care.

In The Last Decade

Andrew Creamer

18 papers receiving 367 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Idiopathic Pulmonary Fibrosis (IPF): An Overview

2018 267 citations Shaney Barratt, Andrew Creamer et al. profile →

Peers

Countries citing papers authored by Andrew Creamer

Since Specialization

Citations

This map shows the geographic impact of Andrew Creamer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Creamer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Creamer more than expected).

Fields of papers citing papers by Andrew Creamer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Creamer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Creamer. The network helps show where Andrew Creamer may publish in the future.

Co-authorship network of co-authors of Andrew Creamer

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Creamer. A scholar is included among the top collaborators of Andrew Creamer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Creamer. Andrew Creamer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Uptake and 4-week outcomes of an ‘opt-out’ smoking cessation referral strategy in a London-based lung cancer screening setting 2025 ·BMJ Open Respiratory Research ·(unknown), (unknown), (unknown), (unknown), Andrew Creamer, (unknown), (unknown), Jennifer Dickson, Carolyn Horst, Sophie Tisi, Helen Hall, John P. McCabe, (unknown), Anne-Marie Hacker, Laura Farrelly, Neal Navani, Allan Hackshaw, Sam M. Janes, Samantha L. Quaife	1
2	Patients’ experiences of, and psychological responses to, surveillance for pulmonary nodules detected through lung cancer screening 2025 ·BMJ Open Respiratory Research ·(unknown), Andrew Creamer, (unknown), Elizabeth Clark, Jennifer Dickson, Richard W. Lee, Sam M. Janes, Stephen W. Duffy, Samantha L. Quaife	0
3	S76 The SUMMIT study: four-week quit rates amongst individuals referred to stop smoking services following attendance at a lung health check 2023 ·(unknown), (unknown), (unknown), (unknown), Carolyn Horst, Sophie Tisi, Helen Hall, (unknown), Andrew Creamer, (unknown), (unknown), Jennie McCabe, (unknown), (unknown), Laura Farrelly, Allan Hackshaw, Samantha L. Quaife, (unknown)	0
4	Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohort 2023 ·BMJ Open Respiratory Research ·Sophie Tisi, Andrew Creamer, Jennifer Dickson, Carolyn Horst, Samantha L. Quaife, Helen Hall, (unknown), (unknown), (unknown), (unknown), Anne-Marie Hacker, (unknown), Laura Farrelly, Arjun Nair, Anand Devaraj, Allan Hackshaw, John R. Hurst, Sam M. Janes	4
5	ERS International Congress 2023: highlights from the Thoracic Oncology Assembly 2023 ·ERJ Open Research ·(unknown), Andrew Creamer, Margarida Dias, (unknown), M. Châabouni, (unknown), (unknown), Maged Hassan, SB Naidu, (unknown), Kevin G. Blyth, Najib M. Rahman, Georgia Hardavella	0
6	Stage at Diagnosis Following Delay to Interval Scans for Indeterminate Nodules in Lung Cancer Screening 2023 ·CHEST Journal ·Andrew Creamer, Carolyn Horst, Jennifer Dickson, Sophie Tisi, Helen Hall, (unknown), (unknown), (unknown), (unknown), John P. McCabe, (unknown), (unknown), Anne-Marie Hacker, Jon W. Teague, Laura Farrelly, (unknown), Allan Hackshaw, Anand Devaraj, Arjun Nair, Sam M. Janes	1
7	Growth patterns of screen-detected malignant pulmonary nodules: Accuracy of doubling-time models 2023 ·Lung Cancer ·Andrew Creamer, Carolyn Horst, Jennifer Dickson, Sophie Tisi, Helen Hall, (unknown), (unknown), (unknown), (unknown), (unknown), Anne-Marie Hacker, Laura Farrelly, (unknown), Anand Devaraj, Arjun Nair, Allan Hackshaw, Sam M. Janes	1
8	Growing small solid nodules in lung cancer screening: safety and efficacy of a 200 mm³minimum size threshold for multidisciplinary team referral 2022 ·Thorax ·Andrew Creamer, Carolyn Horst, Jennifer Dickson, Sophie Tisi, Helen Hall, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Laura Farrelly, Allan Hackshaw, Arjun Nair, Anand Devaraj, Sam M. Janes	4
9	Use of peripheral neutrophil to lymphocyte ratio and peripheral monocyte levels to predict survival in fibrotic hypersensitivity pneumonitis (fHP): a multicentre retrospective cohort study 2021 ·BMJ Open Respiratory Research ·Shaney Barratt, Andrew Creamer, Huzaifa Adamali, Anna Duckworth, (unknown), (unknown), (unknown), (unknown), (unknown), Bibek Gooptu, Michael Gibbons, Felix Woodhead, Chris J. Scotton	7
10	SUMMIT Study: Quality of Spirometry Performed as Part of a ‘Lung Health Check’ (LHC) Assessment for Inclusion into Low Dose Computed Tomography (LDCT) Lung Cancer Screening (LCS) 2021 ·Sophie Tisi, Jeanette Dickson, Carolyn Horst, Helen Hall, (unknown), Andrew Creamer, (unknown), Rachael Sarpong, (unknown), Laura Farrelly, (unknown), (unknown), (unknown), Allan Hackshaw, John R. Hurst, Sam M. Janes	1
11	Delayed interval scanning is not associated with stage-shift at diagnosis: Preliminary results to support guidelines for lung cancer screening during the COVID-19 pandemic 2021 ·Lung Cancer ·Andrew Creamer, Jennifer Dickson, Carolyn Horst, Sophie Tisi, Helen Hall, (unknown), John P. McCabe, (unknown), (unknown), Laura Farrelly, Christina Clark, Stephanie Hamilton, Brian Allen, Allan Hackshaw, Anand Devaraj, Arjun Nair, Sam M. Janes	1
12	Prognostic factors in chronic hypersensitivity pneumonitis 2020 ·European Respiratory Review ·Andrew Creamer, Shaney Barratt	20
13	Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial 2019 ·Breathe ·Andrew Creamer, Shaney Barratt	2
14	Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy 2019 ·Breathe ·Andrew Creamer, (unknown), Mahableshwar Albur	29
15	Carbimazole-induced pancytopaenia 2016 ·British Journal of Hospital Medicine ·(unknown), Andrew Creamer, (unknown)	4
16	Headache in an HIV positive patient: diagnostic challenges and approach to treatment 2016 ·Clinical Medicine ·Andrew Creamer, (unknown), Thomas Wilhelm, (unknown), Marc Lipman	7
17	Factors predicting resolution in nitrofurantoin-induced lung disease 2016 ·Andrew Creamer, (unknown), (unknown), Sam Hare, Rama Vancheeswaran	0
18	Improving smoking cessation policy by assessing user demand for an inpatient smoking cessation service in adult psychiatric wards 2015 ·BMJ Quality Improvement Reports ·Kathy Liu, Andrew Creamer	2
19	Imaging in severe sepsis and septic shock: is early radiological identification of occult sources of infection needed? 2014 ·Critical Care ·Andrew Creamer, J. M. Keep	3
20	Effect of Relaxation Therapy On Post-Myocardial Infarction Patients?? Rehabilitation 1988 ·Nursing Research ·Barbara Hazard Munro, Andrew Creamer, (unknown), (unknown)	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact